A. Barnadas Molins

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred

D. E. Genis, T. Matilla, V. Volpini et al. · Neurology · 1995 · 141 citations · Full text

Life Sciences, Genetics, Neurology +17

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the <i>SCA1</i> CAG-repeat in a large pedigree displaying anticipation and parental male bias

T. Matilla, V. Volpinl, D. E. Genis et al. · Human Molecular Genetics · 1993 · 84 citations

Life Sciences, Genetics, Molecular Genetics +15